DIAYX | MNWBX | DIAYX / MNWBX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 13 years | 10 years | - |
Gain YTD | 10.517 | 6.112 | 172% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 500000 | 1000 | 50,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.76B | 36M | 4,900% |
Annual Yield % from dividends | 2.12 | 0.00 | - |
Returns for 1 year | 13.13 | 6.49 | 202% |
Returns for 3 years | -2.47 | 6.87 | -36% |
Returns for 5 years | 9.96 | 10.52 | 95% |
Returns for 10 years | 31.91 | 20.22 | 158% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MAAWX | 10.09 | N/A | N/A |
Morgan Stanley US Focus Real Estate I | |||
JPPEX | 68.17 | -0.51 | -0.74% |
JPMorgan Mid Cap Equity R6 | |||
GINUX | 28.00 | -0.51 | -1.79% |
Goldman Sachs Small Cap Gr Insghts R6 | |||
NSNRX | 50.69 | -1.06 | -2.05% |
Neuberger Berman Small Cap Growth R3 | |||
ETCHX | 29.89 | -1.49 | -4.75% |
Eventide Healthcare & Life Sciences C |